Search Results - "Verbeek, Joost G. E."

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation by Verbeek, Joost G E, de Jong, Vincent M T, Wijnja, Hanna M, Jager, Agnes, Linn, Sabine C, Retèl, Valesca P, van Harten, Wim H

“…High-dose chemotherapy with autologous stem cell rescue (HDCT) is a promising treatment for patients with stage III, HER2-negative, homologous recombination…”
Get full text

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms by Verbeek, Joost G. E., Atema, Vera, Mewes, Janne C., van Leeuwen, Marieke, Oldenburg, Hester S. A., van Beurden, Marc, Hunter, Myra S., van Harten, Wim H., Aaronson, Neil K., Retèl, Valesca P.

“…Purpose Internet-based cognitive behavioral therapy (iCBT), with and without therapist support, is effective in reducing treatment-induced menopausal symptoms…”
Get full text

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis by Verbeek, Joost G. E., van der Sluis, Karen, Vollebergh, Marieke A., van Sandick, Johanna W., van Harten, Wim H., Retèl, Valesca P.

“…Background Gastric cancer patients with peritoneal carcinomatosis (PC) have a poor prognosis, with a median overall survival of 10 months when treated with…”
Get full text

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers by Verbeek, Joost G E, Azarang, Leyla, Pilli, Luis E, De Jong, Vincent M T, Jager, Agnes, Linn, Sabine C, Retèl, Valesca P, Van Harten, Wim H

“…High-dose chemotherapy with autologous stem cell rescue (HDCT) is currently under investigation as a potential therapy for patients with stage III…”
Get full text